Skip to main content
. 2022 Jan 13;16(8):1661–1679. doi: 10.1002/1878-0261.13171

Fig. 7.

Fig. 7

mRNA expression of FAT1‐associated signatures can be used to predict response of radiotherapy in patients with HNSCC. The results of ddPCR‐based expression analysis of 23 genes (NRG1, TCEA3, PCDHGA10, FER1L6, PCDH7, FAM3B, SLC16A8, TFPI2, C19orf46, MT3, DSCAM, KEL, SEMA3A, FRL1, SYNGR1, FUZ, NKX2‐3, AS3MT, SLC7A11, SYCE2, BEX2, C19orf57, and CYP2E1) and FAT1 gene in HNSCC patients with (n = 2; recur) and without (n = 2; nonrecur) recurrence postradiotherapy. Independent samples t‐test was used to compare the values between 2 groups. Poisson error bars are shown for each sample. The number of asterisks denote the level of statistical significance: *P < 0.05 and **P < 0.01. HNSCC, head and neck squamous cell carcinoma; ddPCR, Droplet digital PCR.